Susquehanna International Group
ADPT icon

Susquehanna International Group’s Adaptive Biotechnologies ADPT Stock Holding History

Susquehanna International Group’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$458K Buy
33,000
+12,400
+60% +$198K ﹤0.01% 9905
2025
Q4 		$335K Buy
20,600
+9,100
+79% +$149K ﹤0.01% 9698
2025
Q3 		$172K Sell
11,500
-31,500
-73% -$384K ﹤0.01% 11141
2025
Q2 		$501K Buy
43,000
+26,200
+156% +$238K ﹤0.01% 9172
2025
Q1 		$125K Buy
16,800
+4,000
+31% +$30.7K ﹤0.01% 11374
2024
Q4 		$76.8K Sell
12,800
-18,300
-59% -$101K ﹤0.01% 11496
2024
Q3 		$159K Buy
+31,100
New +$136K ﹤0.01% 10682
2024
Q1 		– Sell
-18,200
Closed -$89.2K – 12059
2023
Q4 		$89.2K Sell
18,200
-2,100
-10% -$9.58K ﹤0.01% 11410
2023
Q3 		$111K Buy
20,300
+7,600
+60% +$50.3K ﹤0.01% 10835
2023
Q2 		$85.2K Sell
12,700
-400
-3% -$2.97K ﹤0.01% 11063
2023
Q1 		$116K Sell
13,100
-561,900
-98% -$4.95M ﹤0.01% 11170
2022
Q4 		$4.39M Buy
575,000
+549,700
+2,173% +$4.28M ﹤0.01% 3434
2022
Q3 		$180K Buy
25,300
+14,300
+130% +$135K ﹤0.01% 10987
2022
Q2 		$89K Sell
11,000
-18,200
-62% -$160K ﹤0.01% 11569
2022
Q1 		$405K Buy
+29,200
New +$459K ﹤0.01% 9510
2021
Q4 		– Sell
-10,300
Closed -$350K – 13026
2021
Q3 		$350K Sell
10,300
-22,600
-69% -$817K ﹤0.01% 10246
2021
Q2 		$1.34M Buy
32,900
+15,000
+84% +$583K ﹤0.01% 6941
2021
Q1 		$721K Sell
17,900
-156,300
-90% -$8.46M ﹤0.01% 8581
2020
Q4 		$10.3M Sell
174,200
-300
-0.2% -$15.5K ﹤0.01% 2458
2020
Q3 		$8.49M Buy
174,500
+119,000
+214% +$5M ﹤0.01% 2380
2020
Q2 		$2.69M Buy
55,500
+31,500
+131% +$1.15M ﹤0.01% 3980
2020
Q1 		$667K Buy
24,000
+10,500
+78% +$293K ﹤0.01% 6307
2019
Q4 		$404K Sell
13,500
-50,900
-79% -$1.46M ﹤0.01% 7408
2019
Q3 		$1.99M Buy
+64,400
New +$2.63M ﹤0.01% 4206

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group's ADPT Position: Q1 2026 in Review

Susquehanna International Group increased its Adaptive Biotechnologies (ADPT) stake by 329% in Q1 2026, buying an estimated $1.93M and bringing the position to 157,817 shares worth $2.19M. The position accounts for ﹤0.01% of the portfolio, ranked #5968.

Susquehanna International Group first reported a position in ADPT in Q3 2019 and has held it in 26 quarters since. The position peaked at $4.03M in Q2 2020. 295 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.

  • Susquehanna International Group held 157,817 shares of Adaptive Biotechnologies worth $2.19M as of Q1 2026.
  • Susquehanna International Group bought 121,002 Adaptive Biotechnologies shares in Q1 2026, an estimated $1.93M.
  • Adaptive Biotechnologies made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5968 holding.
  • Susquehanna International Group first reported a position in Adaptive Biotechnologies in Q3 2019 and has held it in 26 quarters since.
  • Susquehanna International Group's Adaptive Biotechnologies position peaked at $4.03M in Q2 2020.
  • 295 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.